Effects of cannabidiol and Δ9-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review

SA Smith, GH Le, KM Teopiz, ATH Kwan… - Drug Metabolism …, 2024 - Taylor & Francis
Due to legal, political, and cultural changes, the use of cannabis has rapidly increased in
recent years. Research has demonstrated that the cannabinoids cannabidiol (CBD) and Δ9 …

The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review

M Nisar, Z Tasleem, SA Muhammad, A Javid… - Cost Effectiveness and …, 2024 - Springer
Background The direct and indirect costs of chronic kidney disease (CKD) are substantial
and increase over time. Concerns regarding our capacity to manage the financial burden …

[HTML][HTML] Survey of Potential Drug Interactions, Use of Non-Medical Health Products, and Immunization Status among Patients Receiving Targeted Therapies

R Rajj, N Schaadt, K Bezsila, O Balázs, MB Jancsó… - Pharmaceuticals, 2024 - mdpi.com
In recent years, several changes have occurred in the management of chronic
immunological conditions with the emerging use of targeted therapies. This two-phase cross …

Potential Drug–Drug Interactions and Related Factors among Geriatric Outpatients of a Tertiary Care Hospital

T Wannawichate, P Limpawattana - Geriatrics, 2023 - mdpi.com
(1) Background: Drug–drug interactions (DDIs) possess the potential to lead to a range of
clinically significant consequences in the older population.(2) Aims: To investigate the …

[HTML][HTML] Drug use survey to identify significant drug–drug interactions and assess clinical importance in the outpatient setting of a tertiary care hospital

K Chowdhury, A Hazra, S Ghosh… - Indian Journal of …, 2024 - journals.lww.com
OBJECTIVES: Drug–drug interactions (DDIs) are a common problem in pharmacotherapy,
particularly in situations where multiple disorders must be treated at the same time. We …

[HTML][HTML] Risk Factors for Potential Drug-Drug Interactions in Outpatients with Dyslipidemia

N Lalatović, S Pantović… - Iranian Journal of …, 2023 - ncbi.nlm.nih.gov
Background: Patients with dyslipidemia are usually multimorbid and require polypharmacy.
Therefore, it is important to identify potential drug-drug interactions (pDDIs) in time to prevent …

Hospital care organization for patients with multimorbidity-An analysis of a wicked problem

L Weil - 2024 - research.rug.nl
This thesis explored the complexities of hospital care organization for patients with multiple
long term conditions (MLTC) and identified opportunities to better identify patients who …

[PDF][PDF] Potential pharmacokinetic drug-drug interactions in patients attending medical clinics at Teaching Hospital Jaffna: A prescription analysis

V Kajaniya, R Henola, R Wijesiril, N Gamage… - 2024 - repo.jfn.ac.lk
Background and objective: Patients with chronic medical conditions often take multiple
medications and are at the risk of developing clinically significant drug-drug interactions …